Anxiety Clinical Trials in San Jose, CA

32 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder With Comorbid Anxiety and Insomnia	Phase 2	Syndeio Biosciences, Inc	<1 mi
A Study of NTX-1472 in Social Anxiety Disorder	Phase 2	Newleos Therapeutics, Inc.	<1 mi
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder	Phase 3	Vanda Pharmaceuticals	<1 mi
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness	Phase 2	Brigham and Women's Hospital	9 mi
iExposure Intervention for Social Anxiety	N/A	Palo Alto University	16 mi
Testing Mechanisms of Virtual Reality Exposure Therapy for Social Anxiety	N/A	Palo Alto University	16 mi
Sleep Mechanisms Of Regulating Emotions	N/A	Stanford University	16 mi
Pilot Study of RR-HNK in OCD	Phase 1/2	Carolyn Rodriguez	16 mi
MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)	Phase 2	Carolyn Rodriguez	16 mi
Treatment of Parental Anxiety Virtual Reality (VR)	N/A	Stanford University	17 mi
Study of Dextromethorphan in OCD and Related Disorders	Phase 2	Stanford University	17 mi
Efficacy of Nitrous Oxide in OCD: Pilot Study	Phase 2	Stanford University	17 mi
SEEG-Guided DBS for OCD	N/A	Casey H. Halpern, M.D.	17 mi
Parent-Mediated Intervention Targeting Insistence on Sameness for Autistic Children	N/A	Stanford University	17 mi
Stress Management Program	N/A	Stanford University	17 mi
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)	Phase 2	Stanford University	17 mi
The BEAR Program for Women With Trauma Who Have Suicidal Thoughts	N/A	Stanford University	17 mi
Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum Disorders	N/A	Stanford University	17 mi
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety	Phase 3	Otsuka Pharmaceutical Development & Commercialization, Inc.	41 mi
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder	Phase 2	VistaGen Therapeutics, Inc.	41 mi
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder	Phase 2	AbbVie	41 mi
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder	Phase 2	Intra-Cellular Therapies, Inc.	41 mi
GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer	N/A	Stanford University	42 mi
Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation	N/A	University of California, San Francisco	42 mi
Cortical Stimulation to Treat Obsessive Compulsive Disorder	N/A	Andrew Moses Lee, MD, PhD	42 mi
Evaluating the Feasibility of VR for Pediatric Renal Biopsies	N/A	University of California, San Francisco	42 mi
Personalized DBS for OCD Guided by Stereoencephalography Mapping	N/A	Andrew Moses Lee, MD, PhD	42 mi
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)	Phase 3	Definium Therapeutics US, Inc.	42 mi
Discovering Factors in the Clinical Study Journey of Patients With OCD	—	Power Life Sciences Inc.	42 mi
SUpport From PEeRs to Expand Access Study - Community	N/A	University of California, Berkeley	42 mi
Efficacy and Safety of a Proprietary Blend of Ashwagandha Root Extract (Aqueous) in Adult Men and Women With High Stress and Anxiety: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study	N/A	SF Research Institute, Inc.	42 mi
Brain Health & Wellness Classes for Veterans With Traumatic Brain Injury	N/A	East Bay Institute for Research and Education	49 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.